Product Reports Resources Pricing Login Book a demo

BioGeneration Ventures

Venture Capital · Founded 2006 · Naarden, Netherlands

#2 Investor Ranking 2026 Top 1% in Benelux

Investing in the next generation of life sciences companies

38 Portfolio companies+129% in 5 years
3 Unicorns
1 Decacorns
63 Investments
Aug 2026 Last investment
02 · Exits

BioGeneration Ventures’ biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from BioGeneration Ventures’ transaction record.

$46M IPO · 2014
Entered Series ANow $50BHealth
$7.0B acquisition · 2016
Entered SeedHealth
$326M IPO · 2022
Now $2.7BHealth
03 · Portfolio analysis

Where BioGeneration Ventures’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 38 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. Netherlands24
  2. Belgium6
  3. USA4
  4. Germany3
  5. UK3
  6. Canada1
  7. China1
  8. Switzerland1
By sectorCount
  1. Health41
  2. Kids1
By stage enteredCount
  1. Series A16
  2. Seed14
  3. Series B+2
By growth stageCount
  1. Early Growth18
  2. Breakout Stage13
  3. Late Growth12
04 · Portfolio market map

Inside BioGeneration Ventures’ portfolio.

The 38 highest-funded portfolio companies, of 38 tracked.

NewAmsterdam Pharma
Health · Unicorn
$2.7B
Acerta Pharma
Health · Unicorn
$7.0B
Catalym
Health
$600M
VectorY Therapeutics
Health
$568M
Azafaros
Health
$581M
NorthSea Therapeutics
Health
$320M
Citryll
Health
$374M
Confo Therapeutics
Health
$264M
TargED
Health
$178M
RhyGaze
Health
$344M
VarmX
Health
$117M
Mironid
Health
$184M
Kivu Bioscience
Health
$368M
Avidicure
Health
$193M
Complement Therapeutics
Health
$317M
Brenig Therapeutics
Health
$260M
argenx
Health · Decacorn
$50B
Dualyx
Health
$176M
Scenic Biotech
Health
$123M
Dunad Therapeutics
Health
$26M
Cristal Therapeutics
Health
$56M
Mucosis
Health
$25M
Escalier Biosciences
Health
$66M
FundaMental Pharma
Health
$12M
Artica Therapeutics
Health
$53M
Mellon Medical
Health
$18M
Lanthio Pharma
Health
$22M
Tessellate Bio
Health
$35M
River BioMedics
Health
$8.8M
Fibrocor Therapeutics
Health
$8.2M
Phosphoenix
Health
XS Innovations
Health
$4.8M
MDxHealth
Health
$207M
Synthetica Pioneering
China
Tanai Therapeutics
Health
SurgVision
Health
Progentix
Health
SynAffix
Health
05 · Portfolio founders

Where BioGeneration Ventures’ portfolio founders come from.

39 founders across the 43 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. Netherlands22
  2. Belgium7
  3. Germany3
  4. Switzerland2
  5. United Kingdom2
  6. Canada1
  7. France1
  8. United States1
UniversityCount
  1. Leiden University5
  2. Utrecht University4
  3. University of Aberdeen2
  4. University of Amsterdam2
  5. VU Amsterdam2
  6. Avans University of Applied Sciences1
  7. Cornell University1
  8. Ghent University1
  9. IMD Business School1
  10. INSEAD Business School1
Previous companyCount
  1. Galapagos2
  2. ModiQuest2
  3. UMC Utrecht2
  4. Utrecht University2
  5. VUmc2
  6. Ablynx1
  7. Africa Rising1
  8. argenx1
  9. Boer & Croon1
  10. CeMM1